Access is tightly limited: enrollees need high BMI scores and certain health conditions, while patients using GLP-1s for diabetes or sleep apnea are excluded and must navigate prescriptions and prior authorizations
A story in The Economic Times with Rica Bhattacharyya Read more here: Interesting development
164 The NAD + /SIRT1 signaling pathway functions as a central node linking nutrient sensing, autophagy regulation, and ER adaptation
De Prada, P., & Brenchley, J
"For the newer GLP-1 medications, it would be useful to look at whether there are genetic variants, like the variants in PAM , that explain poor responders to their medications." "There are a whole class of medications that are insulin sensitizers, so perhaps we can develop medications that will allow people to be sensitized to GLP-1s or find formulations of GLP-1, like the longer-acting versions, that avoid the GLP-1 resistance." The research has been published in Genome Medicine .
Healthy Skin Drinks 3
